Paper19007973
Urinary levels of Bcl-2 are elevated in ovarian cancer patients.
Anderson NS and 6 others. Gynecol Oncol, 2009. Cited by 28 papers, by iCite.
Cite this record
ConductScience Library. Urinary levels of Bcl-2 are elevated in ovarian cancer patients. Papers, record 19007973. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19007973
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biomarkers, Tumor | Major topic |
| Ovarian Neoplasms | Major topic |
| Proto-Oncogene Proteins c-bcl-2 | Major topic |
| Adult | |
| Aged | |
| Aged, 80 and over | |
| CA-125 Antigen | |
| Cohort Studies | |
| Enzyme-Linked Immunosorbent Assay | |
| Female | |
| Humans | |
| Middle Aged | |
| Neoplasm Staging | |
| Risk Factors |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| P50 CA083639 | NCI NIH HHS | United States | P50CA083639 | PubMed and NIH |
Source NIH RePORTER
References25
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10739647 | The mitochondrion in cell death control: certainties and incognita. | Exp Cell Res | 2000 | https://conductscience.org/library/papers/10739647 | PubMed |
| 2 | 2651469 | The CA 125 tumour-associated antigen: a review of the literature. | Hum Reprod | 1989 | https://conductscience.org/library/papers/2651469 | PubMed |
| 3 | 12102150 | Prostate-specific antigen and insulin-like growth factor binding protein-3 in nipple aspirate fluid are associated with breast cancer. | Cancer Detect Prev | 2002 | https://conductscience.org/library/papers/12102150 | PubMed |
| 4 | 12445249 | P53 and Bcl-2 as prognostic predictors in epithelial ovarian cancer. | Int J Gynecol Cancer | 2002 | https://conductscience.org/library/papers/12445249 | PubMed |
| 5 | 10213218 | Vascular endothelial growth factor levels in ovarian cyst fluid correlate with malignancy. | Clin Cancer Res | 1999 | https://conductscience.org/library/papers/10213218 | PubMed |
| 6 | 18094410 | A novel set of DNA methylation markers in urine sediments for sensitive/specific detection of bladder cancer. | Clin Cancer Res | 2007 | https://conductscience.org/library/papers/18094410 | PubMed |
| 7 | 15899555 | Elevated levels of soluble interleukin-2 receptor in serum of patients with hematological or non-hematological malignancies. | Cancer Detect Prev | 2005 | https://conductscience.org/library/papers/15899555 | PubMed |
| 8 | 18287387 | Cancer statistics, 2008. | CA Cancer J Clin | 2008 | https://conductscience.org/library/papers/18287387 | PubMed |
| 9 | 10688869 | Apoptosis in cancer. | Carcinogenesis | 2000 | https://conductscience.org/library/papers/10688869 | PubMed |
| 10 | 11280784 | Up-Regulation of Bcl-2 in microvascular endothelial cells enhances intratumoral angiogenesis and accelerates tumor growth. | Cancer Res | 2001 | https://conductscience.org/library/papers/11280784 | PubMed |
| 11 | 10739652 | The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems. | Exp Cell Res | 2000 | https://conductscience.org/library/papers/10739652 | PubMed |
| 12 | 10762660 | Elevated levels of urine angiostatin and plasminogen/plasmin in cancer patients. | Int J Mol Med | 2000 | https://conductscience.org/library/papers/10762660 | PubMed |
| 13 | 15569975 | Detection of methylated apoptosis-associated genes in urine sediments of bladder cancer patients. | Clin Cancer Res | 2004 | https://conductscience.org/library/papers/15569975 | PubMed |
| 14 | 8791486 | New members of the Bcl-2 family and their protein partners. | Curr Opin Genet Dev | 1996 | https://conductscience.org/library/papers/8791486 | PubMed |
| 15 | 12205045 | Bcl-2 overexpression in human melanoma cells increases angiogenesis through VEGF mRNA stabilization and HIF-1-mediated transcriptional activity. | FASEB J | 2002 | https://conductscience.org/library/papers/12205045 | PubMed |
| 16 | 17532030 | Urinary mesothelin provides greater sensitivity for early stage ovarian cancer than serum mesothelin, urinary hCG free beta subunit and urinary hCG beta core fragment. | Gynecol Oncol | 2007 | https://conductscience.org/library/papers/17532030 | PubMed |
| 17 | 12931228 | HA14-1 selectively induces apoptosis in Bcl-2-overexpressing leukemia/lymphoma cells, and enhances cytarabine-induced cell death. | Leukemia | 2003 | https://conductscience.org/library/papers/12931228 | PubMed |
| 18 | 15247129 | Lysophospholipids are potential biomarkers of ovarian cancer. | Cancer Epidemiol Biomarkers Prev | 2004 | https://conductscience.org/library/papers/15247129 | PubMed |
| 19 | 14576343 | Bcl-2 on the endoplasmic reticulum: protecting the mitochondria from a distance. | J Cell Sci | 2003 | https://conductscience.org/library/papers/14576343 | PubMed |
| 20 | 10196212 | The role of antiapoptotic Bcl-2 family members in endothelial apoptosis elucidated with antisense oligonucleotides. | J Biol Chem | 1999 | https://conductscience.org/library/papers/10196212 | PubMed |
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38275400 | High-Grade Serous Ovarian Cancer-A Risk Factor Puzzle and Screening Fugitive. | Biomedicines | 2024 | https://conductscience.org/library/papers/38275400 | PubMed |
| 38068422 | Relationships between CD34-, CD105- and bcl-2-Expression Levels and Contrast-Enhanced Ultrasound-Based Differential Diagnosis of Adnexal Tumours. | J Clin Med | 2023 | https://conductscience.org/library/papers/38068422 | PubMed |
| 35166350 | Urinary biomarkers for the detection of ovarian cancer: a systematic review. | Carcinogenesis | 2022 | https://conductscience.org/library/papers/35166350 | PubMed |
| 32130708 | Ovarian Cancer Biomarkers: Moving Forward in Early Detection. | Adv Exp Med Biol | 2020 | https://conductscience.org/library/papers/32130708 | PubMed |
| 31590408 | An Improved Prediction Model for Ovarian Cancer Using Urinary Biomarkers and a Novel Validation Strategy. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31590408 | PubMed |
| 28039447 | Diagnostic accuracy of urine HE4 in patients with ovarian cancer: a meta-analysis. | Oncotarget | 2017 | https://conductscience.org/library/papers/28039447 | PubMed |
| 25866324 | Detection of the HE4 protein in urine as a biomarker for ovarian neoplasms: Clinical correlates. | Gynecol Oncol | 2015 | https://conductscience.org/library/papers/25866324 | PubMed |
| 23112714 | Surface modification on acoustic wave biosensors for enhanced specificity. | Sensors (Basel) | 2012 | https://conductscience.org/library/papers/23112714 | PubMed |
| 22969352 | A urinary Bcl-2 surface acoustic wave biosensor for early ovarian cancer detection. | Sensors (Basel) | 2012 | https://conductscience.org/library/papers/22969352 | PubMed |
| 22481932 | Optimizing molecular-targeted therapies in ovarian cancer: the renewed surge of interest in ovarian cancer biomarkers and cell signaling pathways. | J Oncol | 2012 | https://conductscience.org/library/papers/22481932 | PubMed |
| 22219597 | Serum Bcl-2 concentrations in overweight-obese subjects with nonalcoholic fatty liver disease. | World J Gastroenterol | 2011 | https://conductscience.org/library/papers/22219597 | PubMed |
| 21928247 | -The advancement of biomarker-based diagnostic tools for ovarian, breast, and pancreatic cancer through the use of urine as an analytical biofluid. | Int J Biol Markers | 2011 | https://conductscience.org/library/papers/21928247 | PubMed |
| 21817115 | Dual-fluorescence isogenic high-content screening for MUC16/CA125 selective agents. | Mol Cancer Ther | 2011 | https://conductscience.org/library/papers/21817115 | PubMed |
| 20477415 | Early detection of ovarian cancer. | Biomark Med | 2008 | https://conductscience.org/library/papers/20477415 | PubMed |
| 20381233 | Detection of the HE4 protein in urine as a biomarker for ovarian neoplasms. | Cancer Lett | 2010 | https://conductscience.org/library/papers/20381233 | PubMed |
| 20332277 | Urine collection and processing for protein biomarker discovery and quantification. | Cancer Epidemiol Biomarkers Prev | 2010 | https://conductscience.org/library/papers/20332277 | PubMed |
| 19879639 | Current state of biomarker development for clinical application in epithelial ovarian cancer. | Gynecol Oncol | 2010 | https://conductscience.org/library/papers/19879639 | PubMed |
| 19865799 | A coumarin derivative (RKS262) inhibits cell-cycle progression, causes pro-apoptotic signaling and cytotoxicity in ovarian cancer cells. | Invest New Drugs | 2011 | https://conductscience.org/library/papers/19865799 | PubMed |
| 19852858 | Bcl-2 expression is altered with ovarian tumor progression: an immunohistochemical evaluation. | J Ovarian Res | 2009 | https://conductscience.org/library/papers/19852858 | PubMed |
Genes11
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BCL2 | 596 | PubTator's text mining | https://conductscience.org/library/genes/596 | NCBI Gene |
| BRCA1 | 672 | PubTator's text mining | https://conductscience.org/library/genes/672 | NCBI Gene |
| CYCS | 54205 | PubTator's text mining | https://conductscience.org/library/genes/54205 | NCBI Gene |
| HIF1A | 3091 | PubTator's text mining | https://conductscience.org/library/genes/3091 | NCBI Gene |
| IGFBP3 | 3486 | PubTator's text mining | https://conductscience.org/library/genes/3486 | NCBI Gene |
| IL2 | 3558 | PubTator's text mining | https://conductscience.org/library/genes/3558 | NCBI Gene |
| KLK3 | 354 | PubTator's text mining | https://conductscience.org/library/genes/354 | NCBI Gene |
| MSLN | 10232 | PubTator's text mining | https://conductscience.org/library/genes/10232 | NCBI Gene |
| MUC16 | 94025 | PubTator's text mining | https://conductscience.org/library/genes/94025 | NCBI Gene |
| PLG | 5340 | PubTator's text mining | https://conductscience.org/library/genes/5340 | NCBI Gene |
| VEGFA | 7422 | PubTator's text mining | https://conductscience.org/library/genes/7422 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19007973
GET https://conductscience.org/api/papers/v1/19007973/references?page=2